APA Zitierstil

Zirakzadeh, A. A., Kinn, J., Krantz, D., Rosenblatt, R., Winerdal, M. E., Hu, J., . . . Winqvist, O. (2017). Doxorubicin enhances the capacity of B cells to activate T cells in urothelial urinary bladder cancer. Clinical immunology (Orlando, Fla.), 176, 63. https://doi.org/10.1016/j.clim.2016.12.003

Chicago Zitierstil

Zirakzadeh, A Ali, et al. "Doxorubicin Enhances the Capacity of B Cells to Activate T Cells in Urothelial Urinary Bladder Cancer." Clinical Immunology (Orlando, Fla.) 176 (2017): 63. https://dx.doi.org/10.1016/j.clim.2016.12.003.

MLA Zitierstil

Zirakzadeh, A Ali, et al. "Doxorubicin Enhances the Capacity of B Cells to Activate T Cells in Urothelial Urinary Bladder Cancer." Clinical Immunology (Orlando, Fla.), vol. 176, 2017, p. 63.